Boston Scientific (BSX) has invested USD 1.5bln for an approximately 34% equity stake in MiRus

Boston Scientific's $1.5 billion investment for a 34% stake in MiRus highlights their strategic focus on expanding their product offerings, particularly in the cardiovascular space with the TAVR system.

Newsquawk StaffPublished 18 May 2026, 10:51 UTCOn the live feed at 10:31 UTC — 4 more headlines followed before this page went public

Newsquawk headlinesUTC

10:40

Commerzbank (CBK GY) Board and Supervisors have recommended holders not accept UniCredit (UCG IM) exchange offer

10:36

Brazil Foreign Minister says they are ready to boost crude oil exports to Japan, Nikkei reports

10:31

Boston Scientific (BSX) has invested USD 1.5bln for an approximately 34% equity stake in MiRus

10:29

EU Commission Spokesperson says steel safeguards should apply to all EU partners including Switzerland

10:17

UK Treasury reforms will give the PRA more flexibility to update and tailor rules over time, while a new growth allowance will let major banks use a limited portion of their balance sheets more flexibly

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

The agreement includes an exclusive option to acquire MiRus's SIEGEL Balloon Expandable TAVR system through additional aggregate cash payments of USD 3bln, contingent on clinical and regulatory milestones.
The investment is expected to be immaterial to adj. earnings per share in 2026.

Context

While the financial impact on adjusted earnings per share in 2026 is expected to be immaterial, this acquisition could bolster BSX's long-term growth and innovation trajectory, potentially positioning the company favorably within the healthcare equipment sector.

FX · last 90 days

Recent headlines that moved markets

FX/28 Aug · 14:00 UTC

Fed Chair Warsh says Fed has more work to do unless confident underlying inflation is moving towards 2% objective

DXY, after we published+0.5%

DXY saw two-way action, before then moving to a high. - Immediately after the release, Fed market pricing moved to price in a 50% chance of a hike in September vs 36% pre-release.

FX/7 Sept · 06:00 UTC

Swedish CPIF Prel (Aug YY) 0.7% vs. Exp. 0.8% (Prev. 0.7%).

With EUR/SEK, after we published+0.3%

FX/4 Sept · 12:39 UTC

Airbus (AIR FP) reportedly reaches a pre-agreement with Spanish unions, Democrata reports.

Market, after we published+1.4%

FX/4 Sept · 12:30 UTC

US Non Farm Payrolls (Aug) 162K vs. Exp. 56K (Prev. 21K); 2-month net revision +55k; Birth-Death 154K.

- DXY, after we published−2.4%

FX/4 Sept · 12:30 UTC

US Non Farm Payrolls (Aug) 162K vs. Exp. 56K (Prev. 21K); 2-month net revision +55k; Birth-Death 154K.

- DXY, after we published+0.4%

FX/4 Sept · 08:30 UTC

BoE DMP (Aug): 1-year CPI expectation 3.1% (prev. 3.4%), 3-year CPI expectation 2.8% (prev. 2.8%).

Market, after we published+0.3%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.